Geneva Capital Management’s Option Care Health OPCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.9M Sell
1,093,941
-380,180
-26% -$8.84M 0.53% 55
2026
Q1
$39.7M Buy
1,474,121
+239,145
+19% +$7.76M 0.84% 41
2025
Q4
$39.3M Sell
1,234,976
-134,886
-10% -$3.96M 0.74% 50
2025
Q3
$38M Buy
1,369,862
+296,216
+28% +$8.58M 0.65% 52
2025
Q2
$34.9M Buy
1,073,646
+292,021
+37% +$9.44M 0.58% 55
2025
Q1
$27.3M Buy
781,625
+38,105
+5% +$1.2M 0.51% 63
2024
Q4
$17.2M Sell
743,520
-44,958
-6% -$1.14M 0.3% 83
2024
Q3
$24.7M Buy
+788,478
New +$24.2M 0.41% 78

Other funds holding OPCH

Geneva Capital Management's OPCH Position: Q2 2026 in Review

Geneva Capital Management reduced its Option Care Health (OPCH) stake by 26% in Q2 2026, selling an estimated $8.84M and leaving 1,093,941 shares worth $22.9M. The position accounts for 0.53% of the portfolio, ranked #55.

Geneva Capital Management first reported a position in OPCH in Q3 2024 and has held it in 8 quarters since. The position peaked at $39.7M in Q1 2026. 371 funds tracked by Wall St. Rank hold OPCH as of Q2 2026.

  • Geneva Capital Management held 1,093,941 shares of Option Care Health worth $22.9M as of Q2 2026.
  • Geneva Capital Management sold 380,180 Option Care Health shares in Q2 2026, an estimated $8.84M.
  • Option Care Health made up 0.53% of Geneva Capital Management's portfolio in Q2 2026, its #55 holding.
  • Geneva Capital Management first reported a position in Option Care Health in Q3 2024 and has held it in 8 quarters since.
  • Geneva Capital Management's Option Care Health position peaked at $39.7M in Q1 2026.
  • 371 funds tracked by Wall St. Rank held Option Care Health as of Q2 2026.

Based on Geneva Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.